Blog

Off-Label

Par Pharmaceuticals Pleads Guilty to Civil & Criminal Allegations of Off-Label Marketing

Par Pharmaceuticals recently pled guilty in federal court to charges of off-label marketing and will be forced to pay $45 million in order to resolve the company's criminal and civil liability. Par allegedly promoted its prescription drug, Megace ES, for off-label uses that were not approved as safe or effective by the Food and Drug [...]

By | 2018-09-21T14:16:57+00:00 March 5th, 2013|Healthcare Fraud|